-
: Designing, synthesizing, and optimizing molecules targeting GPCRs (cannabinoid receptors; allosteric and orthosteric) and ion channels (α4β2 nAChR, α7nAChR, α9* nAChR, GIRK1/2, GIRK1/4, etc.) Conducting
-
across all aspects of medicinal chemistry, including: Designing, synthesizing, and optimizing molecules targeting GPCRs (cannabinoid receptors; allosteric and orthosteric) and ion channels (42 nAChR
-
Fellows will support efforts in either Pharmacometrics (PMx) or Quantitative Systems Pharmacology (QSP). Both fellows will be embedded within Moderna’s Clinical and Quantitative Pharmacology (CQP) function
-
be embedded within Moderna's Clinical and Quantitative Pharmacology (CQP) function and will contribute to key modeling and simulation deliverables for drug candidates across early and late stages
-
of medicinal chemistry. The candidate will be responsible for designing, synthesizing, and optimizing molecules targeting GPCRs (cannabinoid receptors; allosteric and orthosteric) and ion channels (a4b2 nAChR
-
understanding of the other function's responsibilities to enable them to be an optimal collaborator and colleague. During the fellowship, the fellow will work within Regulatory Affairs to gain experience in
-
the opportunity to work closely with our innovative biopharmaceutical industry partners, while engaging with Northeastern University faculty in professional and career development, teaching, service
-
the opportunity to work closely with our innovative biopharmaceutical industry partners, while engaging with Northeastern University faculty in professional and career development, teaching, service
-
the opportunity to work closely with our innovative biopharmaceutical industry partners, while engaging with Northeastern University faculty in professional and career development, teaching, service